Johnson & Johnson (JNJ) Shares Up 53% in Past Year
Published on 6/14/2026
AI Summary
Summarized by AI from the source belowJohnson & Johnson (JNJ) shares have gained 53% over the past year and are up 15% year-to-date. Leerink Partners upgraded JNJ's shares on May 13th, raising the price target from $252 to $265. The firm believes that JNJ's new drugs will contribute to revenue growth and share price performance. Additionally, JNJ has seen a 7.7% increase in share price over the past month amid market liquidity issues.
Get the free market brief
Top stories and analysis, summarized. No spam, unsubscribe anytime.
